As in colorectal cancer, expression of CDX2, VEGF-A, and EGFR was observed in the majority of cases, but HER2/neu expression and loss of PTEN expression are rare oncogenic abnormalities in this cancer. This evidence concerns the gene ERBB2 and colorectal cancer.